Listar Artículos de revista DCS - OZS Aldizkari artikuluak por tema "MRNA-1273"
Mostrando ítems 1-1 de 1
-
Mrna vaccines against sars-cov-2: advantages and caveats
The application of BNT162b2 and mRNA-1273 vaccines against SARS-CoV-2 infection has constituted a determinant resource to control the COVID-19 pandemic. Since the beginning of 2021, millions of doses have been administered ...